Literature DB >> 20036760

Refractory lymphocytic enterocolitis and tumor necrosis factor antagonist therapy.

Ghazaleh Aram1, Theodore M Bayless, Zong-Ming Chen, Elizabeth A Montgomery, Mark Donowitz, Francis M Giardiello.   

Abstract

BACKGROUND & AIMS: Lymphocytic enterocolitis is a malabsorptive syndrome characterized by severe small-bowel villous abnormality and crypt hyperplasia and dense infiltrate of lymphocytes throughout the gastrointestinal tract.
METHODS: We present 2 patients with lymphocytic enterocolitis refractory to usual medical therapy who were treated with tumor necrosis factor antagonists.
RESULTS: Both patients had clinical improvement in diarrheal symptoms and intestinal histologic abnormalities.
CONCLUSIONS: Tumor necrosis factor-alpha antagonists such as infliximab or adalimumab may be a new treatment option for patients with severe refractory lymphocytic enterocolitis not responding to corticosteroids. Copyright 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  diarrhea; lymphocytic enterocolitis; refractory sprue; tumor necrosis factor antagonist

Mesh:

Substances:

Year:  2009        PMID: 20036760      PMCID: PMC2846972          DOI: 10.1016/j.cgh.2009.12.010

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  12 in total

Review 1.  Refractory coeliac disease: remission with infliximab and immunomodulators.

Authors:  Sue M Turner; Moorghen Moorghen; Chris S J Probert
Journal:  Eur J Gastroenterol Hepatol       Date:  2005-06       Impact factor: 2.566

2.  Treatment of idiopathic lymphocytic enterocolitis with oral beclomethasone dipropionate.

Authors:  R M Rai; T R Hendrix; C Moskaluk; D S Levine; P J Pasricha
Journal:  Am J Gastroenterol       Date:  1997-01       Impact factor: 10.864

3.  Steroid-resistant lymphocytic enterocolitis and bronchitis responsive to 6-mercaptopurine in an adolescent.

Authors:  C Deslandres; J B Moussavou-Kombilia; P Russo; E G Seidman
Journal:  J Pediatr Gastroenterol Nutr       Date:  1997-09       Impact factor: 2.839

4.  Lymphocytic and collagenous colitis: an immunohistochemical study.

Authors:  J F Mosnier; L Larvol; J Barge; S Dubois; G De La Bigne; D Hénin; M Cerf
Journal:  Am J Gastroenterol       Date:  1996-04       Impact factor: 10.864

5.  Successful infliximab treatment for steroid-refractory celiac disease: a case report.

Authors:  Helen R Gillett; Ian D R Arnott; Margaret McIntyre; Simon Campbell; Anna Dahele; Matthew Priest; Robert Jackson; Subrata Ghosh
Journal:  Gastroenterology       Date:  2002-03       Impact factor: 22.682

6.  Diagnosis and management of microscopic colitis syndrome.

Authors:  Lawrence R Schiller
Journal:  J Clin Gastroenterol       Date:  2004 May-Jun       Impact factor: 3.062

7.  Lymphocytic enterocolitis in patients with 'refractory sprue'.

Authors:  R N DuBois; A J Lazenby; J H Yardley; T R Hendrix; T M Bayless; F M Giardiello
Journal:  JAMA       Date:  1989-08-18       Impact factor: 56.272

8.  Budesonide in the treatment of refractory celiac disease.

Authors:  Pardeep Brar; Susie Lee; Suzanne Lewis; Ikenna Egbuna; Govind Bhagat; Peter H R Green
Journal:  Am J Gastroenterol       Date:  2007-06-20       Impact factor: 10.864

9.  Refractory coeliac sprue is a diffuse gastrointestinal disease.

Authors:  V Verkarre; V Asnafi; T Lecomte; N Patey Mariaud-de Serre; M Leborgne; E Grosdidier; C Le Bihan; E Macintyre; C Cellier; N Cerf-Bensussan; N Brousse
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

10.  Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease.

Authors:  Jan M H Van den Brande; Henri Braat; Gijs R van den Brink; Henri H Versteeg; Christiaan A Bauer; Inge Hoedemaeker; Catherine van Montfrans; Daan W Hommes; Maikel P Peppelenbosch; Sander J H van Deventer
Journal:  Gastroenterology       Date:  2003-06       Impact factor: 22.682

View more
  5 in total

1.  Microscopic colitis: clinical characteristics, treatment and outcomes in an Irish population.

Authors:  Aoibhlinn O'Toole; Alan Coss; Grainne Holleran; Denise Keegan; Glen Doherty; Kieran Sheahan; Hugh Mulcahy; Diarmuid O'Donoghue
Journal:  Int J Colorectal Dis       Date:  2014-04-18       Impact factor: 2.571

Review 2.  Microscopic colitis: A review of etiology, treatment and refractory disease.

Authors:  Tina Park; David Cave; Christopher Marshall
Journal:  World J Gastroenterol       Date:  2015-08-07       Impact factor: 5.742

Review 3.  Microscopic colitis.

Authors:  Gianluca Ianiro; Giovanni Cammarota; Luca Valerio; Brigida Eleonora Annicchiarico; Alessandro Milani; Massimo Siciliano; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2012-11-21       Impact factor: 5.742

4.  Cytokine expression of microscopic colitis including interleukin-17.

Authors:  Eun-Kyoung Park; Young Sook Park; Dae Rim Park; Sung Ae Jung; Dong Soo Han; Byung Ik Jang; Young Ho Kim; Won Ho Kim; Yun Ju Jo; Ki Ho Lee; Won Mi Lee; Eun Kyung Kim; Hae Soo Koo
Journal:  Gut Liver       Date:  2015-05-23       Impact factor: 4.519

Review 5.  Diagnosis and management of microscopic colitis: current perspectives.

Authors:  Johan Bohr; Anna Wickbom; Agnes Hegedus; Nils Nyhlin; Elisabeth Hultgren Hörnquist; Curt Tysk
Journal:  Clin Exp Gastroenterol       Date:  2014-08-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.